• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Inside Philanthropy

Inside Philanthropy

Go beyond 990s.

Facebook LinkedIn X
  • Grant Finder
  • For Donors
  • Learn
    • Explainers
    • State of American Philanthropy
  • Articles
    • Arts and Culture
    • Civic
    • Economy
    • Education
    • Environment
    • Global
    • Health
    • Science
    • Social Justice
  • Places
  • Jobs
  • Search Our Site

Philanthropy’s Leader in the Fight Against Lyme Disease Launches a Dedicated Treatment Center

Paul Karon | April 21, 2021

Share on Facebook Share on LinkedIn Share on X Share via Email
Banner for article Philanthropy’s Leader in the Fight Against Lyme Disease Launches a Dedicated Treatment Center
PHOTO: Kyle Besler/SHUTTERSTOCK

It’s springtime, summer is around the corner, and folks everywhere can’t wait to get outside. Unfortunately, outside is where ticks live.

Back in 2019, we spoke to people at the Steven and Alexandra Cohen Foundation about their work to combat Lyme and other tick-borne diseases. Ticks are objectively gross enough on their own, but the diseases they spread are the real danger. They’re among the fastest-growing infectious diseases in the country. Latest CDC estimates count about 476,000 cases a year, up considerably from their previous estimate of 329,000.

While most people are cured by the current standard antibiotic treatment, an estimated 10 to 20% of Lyme patients fail to get better and go on to develop chronic and potentially debilitating symptoms that can last for months or years. That’s where the serious concern lies.

The challenges facing Lyme patients are multifaceted. There’s a lack of Lyme literacy among doctors—it’s a cagey disease that imitates other common conditions. The existing treatments are far from perfect, even when a patient is correctly diagnosed. And there’s a lack of dependable diagnostic methods to determine who is actually sick and with which specific tick-borne disease. Add to the mix a dearth of public and private funding for solutions to all of the above.

The Cohen Foundation, spurred on by Alexandra’s firsthand experience with chronic Lyme, had become the largest private funder of tick-borne disease causes in the country, and likely the world, giving out around $60 million over the last five years. One of the major initiatives they discussed with us back in 2019 was their vision to establish a truly Lyme-focused treatment center in the New York City area—the Northeast is one area of heavy Lyme infection. They put out the call for proposals for a “clinical center of excellence” that would advance knowledge of the disease while caring for chronic sufferers who might otherwise have little hope of finding effective treatment. Like so many other things, the process was delayed by the pandemic.

Recently, their vision of a dedicated clinical center finally took shape. The Cohen Foundation announced a $16 million gift to Columbia University to create the Cohen Center for Health and Recovery from Tick-Borne Diseases. The center will provide access to physicians experienced with these diseases, and affordable care—such access is a bigger problem than you might expect. With a hard-to-diagnose disease that can present with different symptoms in different people, a comprehensive medical evaluation is a long process. Those with chronic symptoms may need to see doctors frequently, driving costs to prohibitive levels. And of course, not so many doctors are experienced at spotting Lyme or caring for people with chronic cases.

The Cohen Foundation gift will also fund a national clinical trials network that will aim to identify better evidence-based treatments for patients with Lyme and other tick-borne diseases. Along the way, they’ll work to integrate research and physician training. It’s expected to start seeing patients this summer.

“The center has a scientific review committee that’s open to proposals from other researchers,” said Bennett Nemser, senior program officer at the Cohen Foundation. “The idea is to build a wider network around the country, to generate evidence and bring new treatments further down the pipeline.”

Elsewhere in private and public funding, support for Lyme and tick-borne illnesses has grown modestly in recent years, Nemser said. The federal government provides the majority of funding for tick-borne disease research—about $30 million per year—but that hasn’t been sufficient to make serious headway. It’s a problem today that is likely to develop into a much bigger problem in future.

Biologists have discovered significantly increased rates of Lyme infection in the tick population, leading to the development of Lyme hotspots around the country. Currently, the greatest concentrations of ticks are in the Northeast and the upper Midwest. But those of us outside those areas aren’t free from danger. Researchers have found that the warming climate is supporting tick population spread, ticks are migrating, and people are spending more time outdoors. All of this points to a heavier burden of Lyme and tick-borne conditions in future, and a need for even more funding for care and research into medical solutions.

Featured

Why Five Spinal Cord Injury Organizations Teamed Up to Launch a New Venture Philanthropy Fund

The WHO Foundation: Applying a “Start-up Mentality” to the Challenges of Global Health

A Billionaire Couple’s Quest to Cure the Genetic Disorder That Claimed Their Son’s Life

From Grassroots Beginnings, the Pediatric Cancer Research Foundation Now Funds Nationwide

Post-WeWork, the Neumanns Are Still Billionaires. Whatever Happened to Their Philanthropy?

A Public-Private Cancer Funder Backs Team Science and Targets Inequities in Care and Outcomes

A Foundation’s Long Quest to Take on Huntington’s Disease Picks Up Speed

Backed By Sergey Brin, the Newest Force in Parkinson’s Research Looks to Speed Cures

Five Questions for Alice Pomponio, Head of the American Cancer Society’s Impact Investing Arm

How the Leukemia & Lymphoma Society Is Working to Ensure Equitable Access to Care

A Quiet Exodus: Funders Exit HIV Giving Even as Equity Gaps Grow

Paul Allen’s Philanthropic Legacy Continues with Funding for a Brand-New Field of Health Research

Progress on Breast Cancer Hasn’t Been Evenly Distributed. This Funder’s on the Case

Starting With a Big Boost for Rare Disease Research, This Couple Are Ramping Up Their Giving

Military Experience Is Less Common Today, But These Funders Are Staying True to Veterans

A Local Foundation, a Little-Known College, and a Potential HIV and Cancer Breakthrough

Gates Remains Among the Few in Philanthropy to Drive Research for an HIV Vaccine

After a Tragic Diagnosis, a Former NFL Player and His Wife Rally Support for ALS Research

Type 1 Diabetes Is an Overlooked Global Threat. This Health Funder Has Made it a Top Priority

A New Big Gift Tackles the Problem of Inflammatory and Immune-Mediated Disease

Report Finds Scant Funding for Disability Rights and Social Justice — and Points the Way Forward

Can AI Help Locate Low-Cost Cancer Treatments? These Funders Want to Find Out

How Effective is Effective Altruism? A Deep Dive Into Two of Open Philanthropy’s EA-Inspired Programs

Why a Relatively Small Funder Made a Big Donation to Study Neglected Diseases

These Health Research Funders Are Facing Down the Next Pandemic Threat — Whatever It May Be

Six Things to Know About This Billionaire Hedge Fund Manager’s Philanthropy

A Q&A With Stanley Druckenmiller on Priorities, Big Bets and Feeling “Incredibly Privileged”

COVID Won’t be the Last Pandemic. A Top Biomedical Funder Seeks to Get Ahead of Emerging Pathogens

This Wealthy Virginia Family Is Helping Make the State a Biotech Hub

Sergey Brin’s Off-the-Radar Foundation Is Huge — and Growing Fast. Here’s What We Know About It

Enable JavaScript to continue

This site uses JavaScript to verify your account, display articles, and provide other features. Please enable JavaScript or allow scripts for Inside Philanthropy, then reload the page.

Chrome: Open Chrome Settings, then go to Privacy and security > Site settings > JavaScript, and select “Sites can use JavaScript.”
Full Chrome instructions

Safari: Open Safari Settings, then check the Security settings for JavaScript. Make sure JavaScript is enabled, then reload this page.
Full Safari instructions

Edge: Open Edge Settings, then go to Cookies and site permissions > JavaScript, and make sure JavaScript is allowed.
Full Edge instructions

Brave: Click the Brave Shields lion icon in the address bar and allow scripts for this site. If scripts are blocked, article access and account verification may not work.
Full Brave Shields instructions

Return to the home page

Filed Under: IP Articles Tagged With: Diseases, Effective Altruism, Front Page Most Recent, FrontPageMore, Health, Science, Science Research

Primary Sidebar

Find A Grant Square Banner

Receive our newsletter

Donor Advisory Center Banner

Philanthropy Jobs

Check out our Philanthropy Jobs Center or click a job listing for more information.

Girl in a jacket

Footer

Inside Philanthropy Logo
  • LinkedIn
  • X
  • Facebook

Quick Links

 

About Us
Advertising
Contact Us
FAQ
Help
Terms of Use
Privacy Policy
Accessibility

Become a Subscriber

Sign up for a single user or multi-user subscription.

Receive our Newsletter

© 2026 - Inside Philanthropy